Sama Rinda 4

4 · Axonics, Inc. · Filed Feb 2, 2024

Form 4

Period: 2024-01-31

Chief Operating Officer

Transactions

Exercise/Conversion
Common Stock
2024-01-31+28,000→ 83,854 total
Exercise/Conversion
Performance-Based Restricted Stock Units
2024-01-31−17,500→ 0 total
From: 2024-01-31→ Common Stock (17,500 underlying)
Exercise/Conversion
Performance-Based Restricted Stock Units
2024-01-31−10,500→ 0 total
From: 2024-01-31→ Common Stock (10,500 underlying)

Holdings

Footnotes (2)

[F1]The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2024, and provided the reporting person remains in continuous service through January 31, 2024.
[F2]Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2023 and provided the reporting person remains in continuous service through January 31, 2024.

Documents

2 files